Structural basis for strand-transfer inhibitor binding to HIV intasomes

Strengths and weaknesses of an HIV drug Retroviruses replicate by inserting a copy of their RNA, which has been reverse transcribed into DNA, into the host genome. This process involves the intasome, a nucleoprotein complex comprising copies of the viral integrase bound at the ends of the viral DNA. HIV integrase strand-transfer inhibitors (INSTIs) stop HIV from replicating by blocking the viral integrase and are widely used in HIV treatment. Cook et al. describe structures of second-generation inhibitors bound to the simian immunodeficiency virus (SIV) intasome and to an intasome with integrase mutations known to cause drug resistance. Passos et al. describe the structures of the HIV intasome bound to a second-generation inhibitor and to developmental compounds that are promising drug leads. These structures show how mutations can cause subtle changes in the active site that affect drug binding, show the basis for the higher activity of later-generation inhibitors, and may guide development of better drugs. Science, this issue p. 806, p. 810 Single-particle cryo–electron microscopy shows how inhibitors that bind the intasome may allow the development of better drugs against HIV. The HIV intasome is a large nucleoprotein assembly that mediates the integration of a DNA copy of the viral genome into host chromatin. Intasomes are targeted by the latest generation of antiretroviral drugs, integrase strand-transfer inhibitors (INSTIs). Challenges associated with lentiviral intasome biochemistry have hindered high-resolution structural studies of how INSTIs bind to their native drug target. Here, we present high-resolution cryo–electron microscopy structures of HIV intasomes bound to the latest generation of INSTIs. These structures highlight how small changes in the integrase active site can have notable implications for drug binding and design and provide mechanistic insights into why a leading INSTI retains efficacy against a broad spectrum of drug-resistant variants. The data have implications for expanding effective treatments available for HIV-infected individuals.

[1]  P. Volberding HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel. , 2017, Topics in antiviral medicine.

[2]  R. Siliciano,et al.  Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure. , 2016, Annual review of medicine.

[3]  Stephen H Hughes,et al.  Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors , 2017, Journal of medicinal chemistry.

[4]  Anchi Cheng,et al.  Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.

[5]  Nikolaus Grigorieff,et al.  Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å reconstruction of rotavirus VP6 , 2015, eLife.

[6]  Celia A Schiffer,et al.  Combating susceptibility to drug resistance: lessons from HIV-1 protease. , 2004, Chemistry & biology.

[7]  R. Ghirlando,et al.  Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome , 2017, Science.

[8]  Yves Pommier,et al.  Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572) , 2011, Molecular Pharmacology.

[9]  A. Engelman,et al.  Retroviral intasomes arising. , 2017, Current opinion in structural biology.

[10]  K. Shi,et al.  Crystal structure of the Rous sarcoma virus intasome , 2015, Nature.

[11]  Krishnan Ravikumar,et al.  dl‐Threoninium tri­chloro­acetate , 2004 .

[12]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[13]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[14]  Y. Pommier,et al.  4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1 , 2014, Journal of medicinal chemistry.

[15]  D. Hazuda HIV integrase as a target for antiretroviral therapy , 2012, Current opinion in HIV and AIDS.

[16]  Hong Cao,et al.  Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance. , 2013, Chemistry & biology.

[17]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[18]  Alexis Rohou,et al.  cisTEM: User-friendly software for single-particle image processing , 2017, bioRxiv.

[19]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[20]  A. Engelman,et al.  Retroviral DNA Integration , 2016, Chemical reviews.

[21]  C. Schiffer,et al.  Improving Viral Protease Inhibitors to Counter Drug Resistance. , 2016, Trends in microbiology.

[22]  A. Engelman,et al.  A supramolecular assembly mediates lentiviral DNA integration , 2017, Science.

[23]  Randy J. Read,et al.  Phenix - a comprehensive python-based system for macromolecular structure solution , 2012 .

[24]  A. Engelman,et al.  Retroviral intasome assembly and inhibition of DNA strand transfer , 2010, Nature.

[25]  Joseph H. Davis,et al.  Addressing preferred specimen orientation in single-particle cryo-EM through tilting , 2017, Nature Methods.

[26]  Maxwell D. Cummings,et al.  Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance , 2010, Proceedings of the National Academy of Sciences.

[27]  K Henrick,et al.  Electronic Reprint Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions , 2022 .

[28]  J. Riddell 2018 IAS-USA Recommendations for the Use of Antiretroviral Therapy for HIV: Building on Decades of Progress. , 2018, JAMA.

[29]  S. Hughes,et al.  Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants , 2018, Retrovirology.

[30]  Robert Craigie,et al.  HIV DNA integration. , 2012, Cold Spring Harbor perspectives in medicine.

[31]  D. Langley,et al.  The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors. , 2008, Biochemistry.

[32]  Dmitry Lyumkis,et al.  Non-Uniformity of Projection Distributions Attenuates Resolution in Cryo-EM , 2019, bioRxiv.

[33]  W. Chiu,et al.  Measurement of Atom Resolvability in CryoEM Maps with Q-scores , 2019, bioRxiv.

[34]  D. Hazuda,et al.  Resistance to HIV integrase strand transfer inhibitors: in vitro findings and clinical consequences. , 2014, Current opinion in virology.

[35]  Paul D Adams,et al.  Electronic Reprint Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow ): a Tool for Ligand Coordinate and Restraint Generation Biological Crystallography Electronic Ligand Builder and Optimization Workbench (elbow): a Tool for Ligand Coordinate and Restraint Gener , 2022 .

[36]  M. Wainberg,et al.  HIV drug resistance against strand transfer integrase inhibitors , 2017, Retrovirology.

[37]  Dimitry Tegunov,et al.  Real-time cryo–EM data pre-processing with Warp , 2019, Nature Methods.

[38]  S. Hughes,et al.  Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants , 2016, Retrovirology.

[39]  Y. Pommier,et al.  HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases , 2016, ACS chemical biology.

[40]  Christopher Irving,et al.  Appion: an integrated, database-driven pipeline to facilitate EM image processing. , 2009, Journal of structural biology.

[41]  Goedele N. Maertens,et al.  The mechanism of retroviral integration through X-ray structures of its key intermediates , 2010, Nature.

[42]  Chao Yang,et al.  SPARX, a new environment for Cryo-EM image processing. , 2007, Journal of structural biology.

[43]  A. Engelman,et al.  Engineered Hyperactive Integrase for Concerted HIV-1 DNA Integration , 2014, PloS one.

[44]  D. Hazuda,et al.  HIV-1 antiretroviral drug therapy. , 2012, Cold Spring Harbor perspectives in medicine.

[45]  S. Hughes,et al.  Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors , 2014, Journal of visualized experiments : JoVE.

[46]  A. Engelman,et al.  Cryo-EM reveals a novel octameric integrase structure for β-retroviral intasome function , 2016, Nature.

[47]  D. Davies,et al.  Retroviral integrases and their cousins. , 1996, Current opinion in structural biology.

[48]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[49]  S. Hughes,et al.  HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant Mutants , 2018, Antimicrobial Agents and Chemotherapy.